Triax Pharmaceuticals has launched a patient assistance program(PAP) for the prescription acne treatment system Tretin-X(tretinoin). The program is administered through RxHope, a PAP Webportal for uninsured patients.
Triax Pharmaceuticals has launched a patient assistance program (PAP) for the prescription acne treatment system Tretin-X (tretinoin). The program is administered through RxHope, a PAP Web portal for uninsured patients. Now qualified patients will be provided with a supply of Tretin-X and Minocin (minocycline) through their physicians when they apply on-line with their healthcare provider's assistance at http://www.rxhope.com/.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
To go to the Drug Topics homepage, click here http://www.drugtopics.com.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.